Allogenic Hematopoietic Stem Cell Transplantation Outcomes of Patients Aged ≥ 55 Years with Acute Myeloid Leukemia or Myelodysplastic Syndromes in China: A Retrospective Study

The retrospective study enrolled 259 patients aged over 55 years who underwent their first allogenic hematopoietic stem cell transplantation between April 2015 and August 2022.